CDC report on COVID-19 US impact on Antibiotic Resistance

In its report “COVID-19: US impact on antimicrobial resistance, special report 2022,” concluded that the threat of antimicrobial-resistant infections is not only still present but has gotten worse. During the first year of the pandemic, more than 29,400 people died from antimicrobial-resistant infections commonly associated with healthcare. Of these, nearly 40% of the people got the infection while they were in the hospital. CDC’s 2019 estimates show the US burden of antimicrobial resistance was at least 2.8 million antimicrobial-resistant infections occurred in the US each year, and more than 35,000 people died as a result. In the 2019 AR Threats Report, the CDC reported that nationwide investments in prevention drove down deaths from antimicrobial-resistant infections by 18% from 2012 through 2017. CDC data show these reductions continued until 2020. But the pandemic resulted in more resistant infections, increased antibiotic use, and less data and prevention actions. This setback can and must be temporary. If adequately resourced, the US can continue building resilient public health and healthcare systems to protect our nation from antimicrobial resistance. @


No comments

Leave a Reply